imipramine has been researched along with Hepatic Failure in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Excerpt | Relevance | Reference |
---|---|---|
"Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities." | 5.29 | Hepatic failure associated with imipramine therapy. ( Ilan, Y; Reynes, M; Samuel, D; Tur-Kaspa, R, 1996) |
"Imipramine is an antidepressant drug that is rarely associated with mild liver function abnormalities." | 1.29 | Hepatic failure associated with imipramine therapy. ( Ilan, Y; Reynes, M; Samuel, D; Tur-Kaspa, R, 1996) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ilan, Y | 1 |
Samuel, D | 1 |
Reynes, M | 1 |
Tur-Kaspa, R | 1 |
1 other study available for imipramine and Hepatic Failure
Article | Year |
---|---|
Hepatic failure associated with imipramine therapy.
Topics: Antidepressive Agents, Tricyclic; Humans; Imipramine; Liver Failure; Male; Middle Aged | 1996 |